Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Cobenfy

Preclinical

JJoshua A. Lile, Ph.D.

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Cocaine Use Disorder (CUD)Recruiting

Cocaine Use Disorder (CUD)Preclinical

Recruiting

Timeline

Expected Milestones

Q2 2032

PreclinicalRecruiting

Cocaine Use Disorder (CUD)

NCT07624227

Clinical

Trials by Indication[1]

Cocaine Use Disorder (CUD)1 trial

The Impact of Cobenfy Maintenance on Cocaine's Effects

Recruiting·JJoshua A. Lile, Ph.D.·Preclinical·NCT07624227·32 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Cobenfy. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Cobenfy. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Joshua A. Lile, Ph.D. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: JJoshua A. Lile, Ph.D.

Related News